Advertisement
Screener

ACADIA PHARMACEUTICALS INC. (ACAD) Graph

ACAD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $307.96M; Cost of revenue $28.32M; Research and development $81.56M; Selling, general and administrative $160.25M.
  • 2026-03-31: Revenue $268.06M; Cost of revenue $24.79M; Research and development $76.87M; Selling, general and administrative $171.02M.
  • 2025-12-31: Revenue $283.99M*; Cost of revenue $26.23M*; Research and development $84.76M*; Selling, general and administrative $155.62M*.
  • 2025-09-30: Revenue $278.63M; Cost of revenue $21.65M; Research and development $87.83M; Selling, general and administrative $133.40M.

Major Customers

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ACAD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Daybue$124.83MNuplazid$183.13MRevenue$307.96MCost of revenue$28.32MOperating income$37.84MOther income, net$647.00KResearch & development$81.56MSelling, general& administrative$160.25MNet income$31.50M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ACAD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment AggregationBefore Other Operating Segment$307.96MRevenue$307.96MCost of revenue$28.32MOperating income$37.84MOther income, net$647.00KResearch & development$81.56MSelling, general& administrative$160.25MNet income$31.50M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$307.96M$28.32M$81.56M$160.25M(m)$14.97M$31.50M
2026-03-31$268.06M$24.79M$76.87M$171.02M(m)$344.00K$3.64M
2025-12-31$283.99M*$26.23M*$84.76M*$155.62M*(m)-$247.25M*$273.57M*
2025-09-30$278.63M$21.65M$87.83M$133.40M(m)-$27.18M$71.78M
2025-06-30$264.57M$20.73M$77.95M$133.51M(m)$13.54M$26.67M
2025-03-31$244.32M$20.39M$78.27M$126.37M(m)$8.79M$18.99M
2024-09-30$250.40M$18.86M$66.61M$133.29M(m)$6.04M$32.77M
2024-06-30$241.96M$18.23M$76.23M$117.06M(m)$3.79M$33.39M
2024-03-31$205.83M$22.95M$59.68M$107.99M(m)$4.45M$16.55M
2023-12-31$231.04M(m)(m)(m)(m)(m)$45.80M
2023-09-30$211.70M$14.62M$156.96M$97.89M(m)$13.03M-$65.18M
2023-06-30$165.24M$7.46M$58.77M$95.97M(m)$5.23M$1.11M
2023-03-31$118.46M$1.67M$69.14M$101.23M(m)-$1.92M-$43.02M
2022-12-31$136.49M(m)(m)(m)(m)(m)-$41.73M
2022-09-30$130.71M$2.14M$81.34M$78.11M(m)$768.00K-$27.18M
2022-06-30$134.56M$2.67M$75.65M$89.90M(m)$443.00K-$34.01M
2022-03-31$115.47M$2.95M$128.85M$96.68M(m)$485.00K-$113.06M
2021-12-31$130.76M(m)(m)(m)(m)(m)-$43.09M
2021-09-30$131.61M$3.69M$58.56M$81.67M(m)-$332.00K-$14.46M
2021-06-30$115.22M$2.53M$56.94M$96.79M(m)$473.00K-$43.87M
2021-03-31$106.55M$2.19M$56.97M$111.66M(m)$21.00K-$66.45M
2020-12-30$121.01M(m)(m)(m)(m)(m)-$66.76M
2020-09-30$120.58M$2.00M$120.08M$81.59M(m)-$199.00K-$84.66M
2020-06-30$110.10M$2.90M$64.30M$84.34M(m)$393.00K-$42.14M
2020-03-31$90.07M$2.80M$72.64M$101.97M(m)(m)-$88.02M
2019-12-31$98.33M(m)(m)(m)(m)(m)-$53.04M
2019-09-30$94.59M$2.42M$62.62M$72.70M(m)-$264.00K-$41.98M
2019-06-30$83.20M$2.96M$67.32M$67.98M(m)$365.00K-$54.94M
2019-03-31$62.96M$2.95M$52.92M$93.09M(m)$375.00K-$85.30M
2018-12-31$59.57M(m)(m)(m)(m)(m)-$65.49M
2018-09-30$58.30M$3.84M$53.11M$61.09M(m)$376.00K-$62.14M
2018-06-30$57.06M$3.56M$46.59M$69.47M(m)$219.00K-$63.27M
2018-03-31$48.87M$2.15M$39.28M$60.93M(m)$647.00K-$54.30M
2017-12-31$43.56M(m)(m)(m)(m)(m)-$68.87M
2017-09-30$35.58M$2.13M$36.42M$61.59M(m)$667.00K-$65.25M
2017-06-30$30.48M$2.22M$34.18M$61.13M(m)$398.00K-$67.44M
2017-03-31$15.29M(m)$35.41M$65.66M(m)$85.00K-$87.84M
2016-12-31$11.96M(m)(m)(m)(m)(m)-$78.70M
2016-09-30$5.27M(m)$25.81M$50.53M(m)(m)-$71.61M
2016-06-30$97.00K(m)$20.48M$50.77M(m)(m)-$71.32M
2016-03-31$4.00K(m)$22.77M$27.49M$50.27M(m)-$49.76M
2015-12-31$17.00K(m)(m)(m)$45.58M*(m)-$45.78M
2015-09-30$39.00K(m)$18.73M$20.31M$39.04M(m)-$38.91M
2015-06-30$1.00K(m)$18.38M$21.12M$39.50M(m)-$39.38M
2015-03-31$4.00K(m)$16.30M(m)$40.56M(m)-$40.38M
2014-12-31$47.00K(m)(m)(m)(m)(m)-$28.37M
2014-09-30$15.00K(m)$16.95M(m)$25.01M(m)-$24.79M
2014-06-30$28.00K(m)$13.80M(m)$21.75M(m)-$21.50M
2014-03-31$30.00K(m)$11.67M(m)$17.99M(m)-$17.83M
2013-12-31$37.00K(m)(m)(m)(m)(m)-$12.05M
2013-09-30$240.00K(m)$7.25M(m)$11.05M(m)-$10.70M
2013-06-30$451.00K(m)$7.11M(m)$9.61M(m)-$9.08M
2013-03-31$417.00K(m)$4.43M(m)$6.58M(m)-$6.12M
2012-12-31$380.00K(m)(m)(m)(m)(m)-$6.81M
2012-09-30$3.48M(m)$4.40M(m)$5.88M(m)-$2.40M
2012-06-30$599.00K(m)$4.47M(m)$6.03M(m)-$5.42M
2012-03-31$450.00K(m)$5.02M(m)$6.68M(m)-$6.22M
2011-12-31$588.00K(m)(m)(m)(m)(m)-$5.30M
2011-09-30$584.00K(m)$4.16M(m)$5.68M(m)-$5.08M
2011-06-30$460.00K(m)$4.32M(m)$7.04M(m)-$6.56M
2011-03-31$435.00K(m)$4.41M(m)$6.30M(m)-$5.83M
2010-09-30$2.30M(m)$4.96M(m)$6.54M(m)-$4.23M
2010-06-30$2.30M(m)$5.04M(m)$6.59M(m)-$4.29M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$576.02M$53.11M$158.42M$331.27M(m)$15.32M$35.14M
2025-06-30$508.88M$41.13M$156.22M$259.88M(m)$22.34M$45.65M
2024-06-30$447.79M$41.18M$135.91M$225.05M(m)$8.24M$49.94M
2023-06-30$283.70M$9.13M$127.92M$197.20M(m)$3.31M-$41.91M
2022-06-30$250.03M$5.62M$204.50M$186.58M(m)$928.00K-$147.07M
2021-06-30$221.78M$4.71M$113.91M$208.45M(m)$494.00K-$110.32M
2020-06-30$200.17M$5.70M$136.93M$186.32M(m)$393.00K-$130.16M
2019-06-30$146.16M$5.91M$120.24M$161.07M(m)$740.00K-$140.25M
2018-06-30$105.93M$5.71M$85.87M$130.40M(m)$866.00K-$117.56M
2017-06-30$45.76M$4.49M$69.59M$126.78M(m)$483.00K-$155.28M
2016-06-30$101.00K(m)$43.25M$78.26M(m)(m)-$121.08M
2015-06-30$5.00K(m)$34.67M$45.38M$80.05M(m)-$79.75M
2014-06-30$58.00K(m)$25.47M(m)$39.74M(m)-$39.32M
2013-06-30$868.00K(m)$11.54M(m)$16.19M(m)-$15.20M
2012-06-30$1.05M(m)$9.49M(m)$12.71M(m)-$11.64M
2011-06-30$895.00K(m)$8.73M(m)$13.34M(m)-$12.39M
2010-06-30$4.43M(m)$10.86M(m)$14.22M(m)-$9.78M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$787.52M$62.77M$244.04M$393.28M(m)-$4.85M$117.43M
2024-09-30$698.20M$60.04M$202.52M$358.35M(m)$14.28M$82.71M
2023-09-30$495.40M$23.75M$284.88M$295.09M(m)$16.34M-$107.08M
2022-09-30$380.75M$7.75M$285.84M$264.69M(m)$1.70M-$174.25M
2021-09-30$353.39M$8.40M$172.47M$290.12M(m)$162.00K-$124.78M
2020-09-30$320.75M$7.70M$257.01M$267.91M(m)$194.00K-$214.82M
2019-09-30$240.75M$8.32M$182.87M$233.77M(m)$476.00K-$182.22M
2018-09-30$164.24M$9.55M$138.98M$191.49M(m)$1.24M-$179.70M
2017-09-30$81.34M$6.62M$106.01M$188.37M(m)$1.15M-$220.53M
2016-09-30$5.37M(m)$69.07M$128.79M(m)(m)-$192.70M
2015-09-30$44.00K(m)$53.40M$65.69M$119.09M(m)-$118.66M
2014-09-30$72.00K(m)$42.42M(m)$64.75M(m)-$64.11M
2013-09-30$1.11M(m)$18.80M(m)$27.24M(m)-$25.90M
2012-09-30$4.53M(m)$13.89M(m)$18.59M(m)-$14.04M
2011-09-30$1.48M(m)$12.88M(m)$19.02M(m)-$17.46M
2010-09-30$6.73M(m)$15.82M(m)$20.77M(m)-$14.00M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$1.07B$89.00M$328.80M$548.89M(m)-$252.10M$391.00M
2024-12-31$957.80M$81.84M$303.25M$488.43M(m)$31.62M$226.00M
2023-12-31$726.44M$41.64M$351.62M$406.56M(m)$10.25M-$61.00M
2022-12-31$517.24M$10.17M$361.57M$369.09M(m)$2.53M-$214.00M
2021-12-31$484.14M$19.14M$239.41M$396.03M(m)$351.00K-$168.00M
2020-12-31$441.75M$10.21M$319.13M$388.66M(m)$611.00K-$281.58M
2019-12-31$339.08M$11.34M$240.38M$325.64M(m)$876.00K-$235.26M
2018-12-31$223.81M$12.38M$187.16M$265.76M(m)$1.26M-$245.19M
2017-12-31$124.90M$9.08M$149.19M$255.06M(m)$1.12M-$289.40M
2016-12-31$17.33M(m)$99.28M$186.46M(m)$1.34M-$271.39M
2015-12-31$61.00K(m)$73.87M$88.30M$164.67M$330.00K-$164.44M
2014-12-31$120.00K(m)$60.60M$32.75M$93.35M$0.00-$92.47M
2013-12-31$1.15M(m)$26.72M(m)$39.44M$0.00-$37.95M
2012-12-31$4.91M(m)$18.79M(m)$25.79M$0.00-$20.85M
2011-12-31$2.07M(m)$17.31M(m)$24.92M$17.00K-$22.77M
2010-12-31$42.13M(m)$20.58M(m)$27.04M$12.00K$15.14M
2009-12-31$6.40M(m)$41.59M(m)$51.87M(m)-$45.15M

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47